Modern Pathology, 1530-0285

Journal

More filtering options
  1. 2020
  2. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells

    Jakob Hofvander, Jo, V. Y., Fletcher, C. D. M., Puls, F., Flucke, U., Nilsson, J., Magnusson, L. & Fredrik Mertens, 2020, In : Modern Pathology.

    Research output: Contribution to journalArticle

  3. 2019
  4. Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases

    Al-Ibraheemi, A., Folpe, A. L., Perez-Atayde, A. R., Perry, K., Jakob Hofvander, Elsa Arbajian, Magnusson, L., Nilsson, J. & Fredrik Mertens, 2019, In : Modern Pathology. 32, 3, p. 423-434

    Research output: Contribution to journalArticle

  5. 2018
  6. Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53

    Høland, M., Kolberg, M., Danielsen, S. A., Bjerkehagen, B., Eilertsen, I. A., Hektoen, M., Nils Mandahl, van Den Berg, E., Smeland, S., Fredrik Mertens, Sundby Hall, K., Picci, P., Sveen, A. & Lothe, R. A., 2018 Nov, In : Modern Pathology. 31, 11, p. 1694-1707

    Research output: Contribution to journalArticle

  7. 2017
  8. PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability

    Hans Brunnström, Anna Johansson, Westbom-Fremer, S., Backman, M., Djureinovic, D., Patthey, A., Isaksson-Mettävainio, M., Gulyas, M. & Micke, P., 2017 Oct, In : Modern Pathology. 30, 10, p. 1411-1421

    Research output: Contribution to journalArticle

  9. Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters

    Grinberg, M., Djureinovic, D., Hans RR Brunnström, Mattsson, J. S., Edlund, K., Hengstler, J. G., La Fleur, L., Ekman, S., Koyi, H., Branden, E., Ståhle, E., Karin Jirström, Tracy, D. K., Pontén, F., Botling, J., Rahnenführer, J. & Micke, P., 2017 Jul, In : Modern Pathology. 30, 7, p. 964-977 14 p.

    Research output: Contribution to journalArticle

  10. 2015
  11. An international study to increase concordance in Ki67 scoring.

    Polley, M-Y. C., Leung, S. C. Y., Gao, D., Mastropasqua, M. G., Zabaglo, L. A., Bartlett, J. M. S., McShane, L. M., Enos, R. A., Badve, S. S., Bane, A. L., Borgquist, S., Fineberg, S., Lin, M-G., Gown, A. M., Grabau, D., Gutierrez, C., Hugh, J. C., Moriya, T., Ohi, Y., Osborne, C. K. & 11 others, Penault-Llorca, F. M., Piper, T., Porter, P. L., Sakatani, T., Salgado, R., Starczynski, J., Lænkholm, A-V., Viale, G., Dowsett, M., Hayes, D. F. & Nielsen, T. O., 2015, In : Modern Pathology. 28, 6, p. 778-786

    Research output: Contribution to journalArticle

  12. Familial colorectal cancer type X: genetic profiles and phenotypic features.

    Dominguez, M., Therkildsen, C., Da Silva, S. & Mef Nilbert, 2015, In : Modern Pathology. 28, 1, p. 30-36

    Research output: Contribution to journalArticle

  13. 2014
  14. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

    Doyle, L. A., Vivero, M., Fletcher, C. D. M., Fredrik Mertens & Hornick, J. L., 2014, In : Modern Pathology. 27, 3, p. 390-395

    Research output: Contribution to journalArticle

  15. Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.

    Deb, S., Johansson, I., Byrne, D., Nilsson, C., Investigators, K., Constable, L., Fjällskog, M-L., Dobrovic, A., Ingrid Hedenfalk & Fox, S. B., 2014, In : Modern Pathology. 27, 9, p. 1223-1230

    Research output: Contribution to journalArticle

  16. 2013
  17. High proliferation is associated with inferior Outcome in male breast cancer patients

    Nilsson, C., Koliadi, A., Johansson, I., Ahlin, C., Thorstenson, S., Bergkvist, L., Ingrid Hedenfalk & Fjallskog, M-L., 2013, In : Modern Pathology. 26, 1, p. 87-94

    Research output: Contribution to journalArticle

  18. 2011
  19. 2010
  20. Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma

    Romeo, S., Duim, R. A. J., Bridge, J. A., Fredrik Mertens, De Jong, D., Dal Cin, P., Wijers-Koster, P. M., Debiec, M., Sciot, R., Rosenberg, A., Szuhai, K. & Hogendoorn, P. C. W., 2010, In : Modern Pathology. 23, Suppl. 1, p. 27A

    Research output: Contribution to journalPublished meeting abstract

  21. Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patients

    Riihijarvi, S., Koivula, S., Nyman, H., Fjordén, K., Mats Jerkeman & Leppa, S., 2010, In : Modern Pathology. 23, 5, p. 686-693

    Research output: Contribution to journalArticle

  22. 2009
  23. Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M-L., Banham, A. H. & Leppa, S., 2009, In : Modern Pathology. 22, 8, p. 1094-1101

    Research output: Contribution to journalArticle

  24. 2008
  25. Heterogeneous genetic profiles in soft tissue myoepitheliomas

    Karolin Hansén Nord, Teixeira, M. R., Fletcher, C. D. M., Bizarro, S., Johan Staaf, Domanski, H., Fredrik Vult von Steyern, Panagopoulos, I., Nils Mandahl & Fredrik Mertens, 2008, In : Modern Pathology. 21, 11, p. 1311-1319

    Research output: Contribution to journalArticle

  26. 2005
  27. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

    Laakso, M., Niklas Loman, Åke Borg & Isola, J., 2005, In : Modern Pathology. 18, 10, p. 1321-1328

    Research output: Contribution to journalArticle

  28. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

    Berglund, M., Thunberg, U., Amini, RM., Book, M., Roos, G., Erlanson, M., Linderoth, J., Michael Dictor, Mats Jerkeman, Cavallin-Ståhl, E., Sundstrom, C., Rehn-Eriksson, S., Backlin, C., Hagberg, H., Rosenquist, R. & Enblad, G., 2005, In : Modern Pathology. 18, 8, p. 1113-1120

    Research output: Contribution to journalArticle

  29. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer.

    Halvarsson, B., Lindblom, A., Johansson, L., Lagerstedt, K. & Mef Nilbert, 2005, In : Modern Pathology. 18, 8, p. 1095-1101

    Research output: Contribution to journalArticle

  30. 2004
  31. 2003
  32. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas

    Dahlén, A., Fredrik Mertens, Anders Rydholm, Brosjö, O., Wejde, J., Nils Mandahl & Panagopoulos, I., 2003 Nov, In : Modern Pathology. 16, 11, p. 1132-1140 9 p.

    Research output: Contribution to journalArticle

  33. 2001
  34. Cloning of the der(17)t(X;17)(p11;q25) of alveolar soft part sarcoma identifies the ASPL-TFE3 gene fusion, a new molecular diagnostic marker

    Ladanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meloni-Ehrig, A., Argani, P., Sorensen, P. H. B., Mertens, F., Nils Mandahl, van den Berghe, H., Sciot, R., Dal Cin, P. & Bridge, J. A., 2001, In : Modern Pathology. 14, 1, p. 14A-14A

    Research output: Contribution to journalArticle

  35. ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization

    Adem, C., David Gisselsson Nord, Cin, P. D. & Nascimento, A. G., 2001, In : Modern Pathology. 14, 12, p. 1246-1251

    Research output: Contribution to journalArticle

  36. 1996